IBEX Technologies Inc.
IBT
Rang in Aktien
#28700
Founded in 1972 and based in Montreal, Canada, IBEX Technologies Inc.... Founded in 1972 and based in Montreal, Canada, IBEX Technologies Inc. specializes in the production and global distribution of enzymes tailored for biomedical applications. The company's reach extends to Canada, the United States, Germany, and the United Kingdom, as well as other international markets. Its extensive product catalog features recombinant glycosaminoglycan lyases, such as Heparinase I, II, and III, along with Chondroitinase AC and B. Furthermore, IBEX offers collagen ELISAs designed to investigate the synthesis and breakdown of connective tissue components, complementing these with collagen antibodies and diamine oxidase liquid. They are also a key provider of arthritis assays, essential for research into osteoarthritis. Beyond their product lines, IBEX delivers lyophilization services for disposable medical device parts, in addition to custom fermentation and contract manufacturing capabilities. Their diverse client base encompasses medical device fabricators, quality control facilities, producers of low molecular weight heparin, and academic research institutions.
Aktienkurs
$1.05
Zuletzt synchronisiert: 2024-04-11
Marktkapitalisierung
$23.31M
Veränderung (1 Tag)
-0.01%
Veränderung (1 Jahr)
5.21%
Land
CA
Handel IBEX Technologies Inc. (IBT)
Kategorie
Healthcare
Kursverlauf für IBEX Technologies Inc. (IBT)
Höchster Schlusskurs: $1.00 am 2024-04-01
Niedrigster Schlusskurs: $0.18 am 2018-08-01
Niedrigster Schlusskurs: $0.18 am 2018-08-01
Kursverlauf der Aktie von IBEX Technologies Inc. von 2018 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2024 | 39.28% |
| 2023 | 66.64% |
| 2022 | 60.33% |
| 2021 | 33.14% |
| 2020 | 119.45% |
| 2019 | -31.94% |
| 2018 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $758.21 | 7.77% |
CH
|
